P. Balancier, F. Georges, S. Jacobs, V. Martin, M. Poumay et al., est-ce qu'apprendre. In : L'E-learning dans l'Enseignement Supérieur -Environnement International Francophone. LAbSET. Mars, p.6, 2006.

. Ministère-de-l'emploi, CIRCULAIRE DGEFP n°2001/22 du 20 juillet 2001 relative aux formations ouvertes et/ou à distance « FOAD

, Référentiel de bonnes pratiques en formation ouverte et à distance, AFNOR, 2004.

, COMPETICE Outil de pilotage par les compétences des projets TICE dans l'enseignement dans l'enseignement supérieur, 2001.

M. Paris-tech, Quelle différence entre l'e-learning et les MOOCs ? MOOC

H. Maisonneuve and O. Chabot, Internet en formation médicale continue : aussi efficace que les formations dites présentielles. Presse Médicale, vol.38, pp.1434-1476, 2009.

B. Ghirardini, F. Landriscina, and B. Shapiro, Méthodologies pour le développement de cours elearning. Un guide pour concevoir et élaborer des cours d'apprentissage numérique. FAO, 2011.

, ?idArticle=LEGIARTI000006278868&cidTexte=LEGITEXT000006069414& dateTexte=20060803 10. Code Civil. Articles 7 à 15

, Code de la Santé Publique. Article L110-4

J. Pottiez, Nouveau modèle de Kirkpatrick : quels apports pour la fonction formation ?

. Le-blog-de-c-campus, , 2019.

D. Knights, K. G. Lassen, and R. J. Xavier, Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome, Gut. oct, vol.62, issue.10, pp.1505-1515, 2013.

Q. Guan, A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease, J Immunol Res, p.7247238, 2019.

K. L. Glassner, B. P. Abraham, and E. Quigley, The microbiome and inflammatory bowel disease, J Allergy Clin Immunol. janv, vol.145, issue.1, pp.16-27, 2020.

J. P. Hugot, M. Chamaillard, H. Zouali, S. Lesage, J. P. Cézard et al., Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease, Nature. 31 mai, vol.411, issue.6837, pp.599-603, 2001.

N. C. Knox, J. D. Forbes, C. Peterson, G. Van-domselaar, and C. N. Bernstein, The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases, Am J Gastroenterol. juill, vol.114, issue.7, pp.1051-70, 2019.

W. Y. Mak, M. Zhao, S. C. Ng, and J. Burisch, The epidemiology of inflammatory bowel disease: East meets west, J Gastroenterol Hepatol, 2019.

S. C. Ng, H. Y. Shi, N. Hamidi, F. E. Underwood, W. Tang et al., Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies, Lancet Lond Engl, vol.23, pp.2769-78, 2018.

R. Altwegg and L. Peyrin-biroulet, Maladie de Crohn chez l'adulte, EMC-Gastro-entérologie, vol.11, issue.3, pp.1-18, 2016.

A. Buisson, G. Bommelaer, and L. Peyrin-biroulet, Rectocolite hémorragique : épidémiologie, physiopathologie, diagnostic, histoire naturelle et stratégie thérapeutique, EMC-Gastroentérologie, vol.7, issue.4, pp.1-19, 2012.

J. Torres, S. Bonovas, G. Doherty, T. Kucharzik, J. P. Gisbert et al., ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment, J Crohns Colitis. 1 janv, vol.14, issue.1, pp.4-22, 2020.

C. Maaser, A. Sturm, S. R. Vavricka, T. Kucharzik, G. Fiorino et al., ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications, J Crohns Colitis, vol.01, issue.2, pp.144-64, 2019.

A. Sturm, C. Maaser, E. Calabrese, V. Annese, G. Fiorino et al., ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects, J Crohns Colitis. 26 mars, vol.13, issue.3, pp.273-84, 2019.

M. Harbord, R. Eliakim, D. Bettenworth, K. Karmiris, K. Katsanos et al., Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management, J Crohns Colitis. 1 juill, vol.11, issue.7, pp.769-84, 2017.

F. Magro, P. Gionchetti, R. Eliakim, S. Ardizzone, A. Armuzzi et al., Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders, J Crohns Colitis. 1 juin, vol.11, issue.6, pp.649-70, 2017.

B. Pariente, J. Cosnes, S. Danese, W. J. Sandborn, M. Lewin et al., Development of the Crohn's disease digestive damage score, the Lémann score, Inflamm Bowel Dis. juin, vol.17, issue.6, pp.1415-1437, 2011.

. Copath and . Mici,

. Umf, Disponible sur, 2013.

C. Hedin, S. R. Vavricka, A. J. Stagg, A. Schoepfer, T. Raine et al., The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy, J Crohns Colitis. 26 avr, vol.13, issue.5, pp.541-54, 2019.

S. R. Vavricka, A. Schoepfer, M. Scharl, P. L. Lakatos, A. Navarini et al., Extraintestinal Manifestations of Inflammatory Bowel Disease, Inflamm Bowel Dis. août, vol.21, issue.8, pp.1982-92, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01667949

M. Harbord, V. Annese, S. R. Vavricka, M. Allez, M. Barreiro-de-acosta et al., The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease, J Crohns Colitis. 1 mars, vol.10, issue.3, pp.239-54, 2016.

E. Delaporte and F. Piette, Peau et affections du tube digestif, EMC -Dermatologie, vol.10, issue.4, pp.1-12, 2015.

J. Seneschal, Manifestations dermatologiques au cours des maladies inflammatoires chroniques de l'intestin

. Fmc-hge, Disponible sur

V. Annese, A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel Disease, Saudi J Med Med Sci. août, vol.7, issue.2, pp.66-73, 2019.

T. Iida, T. Hida, M. Matsuura, H. Uhara, and H. Nakase, Current clinical issue of skin lesions in patients with inflammatory bowel disease, Clin J Gastroenterol. déc, vol.12, issue.6, pp.501-511, 2019.

T. Greuter and S. R. Vavricka, Extraintestinal manifestations in inflammatory bowel diseaseepidemiology, genetics, and pathogenesis, Expert Rev Gastroenterol Hepatol. avr, vol.13, issue.4, pp.307-324, 2019.

S. Timani and D. F. Mutasim, Skin manifestations of inflammatory bowel disease, Clin Dermatol. mai, vol.26, issue.3, pp.265-73, 2008.

T. Greuter, A. Navarini, and S. R. Vavricka, Skin Manifestations of Inflammatory Bowel Disease, Clin Rev Allergy Immunol. déc, vol.53, issue.3, pp.413-440, 2017.

B. Thrash, M. Patel, K. R. Shah, C. R. Boland, and A. Menter, Cutaneous manifestations of gastrointestinal disease, J Am Acad Dermatol. févr, vol.68, issue.2, pp.211-212, 2013.

S. R. Vavricka, M. Gubler, C. Gantenbein, M. Spoerri, F. Froehlich et al., Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study: Inflamm Bowel Dis, vol.23, pp.1174-81, 2017.

M. Fleisher, J. Marsal, S. D. Lee, L. E. Frado, A. Parian et al., Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease, Dig Dis Sci, vol.63, issue.4, pp.825-858, 2018.

Z. Pellicer, J. M. Santiago, A. Rodriguez, V. Alonso, R. Antón et al., Management of cutaneous disorders related to inflammatory bowel disease, Ann Gastroenterol, vol.25, issue.1, pp.21-27, 2012.

T. H. Clayton, B. P. Walker, and G. I. Stables, Treatment of chronic erythema nodosum with infliximab, Clin Exp Dermatol, vol.31, issue.6, pp.823-827, 2006.

A. Quin, S. Kane, and O. Ulitsky, A case of fistulizing Crohn's disease and erythema nodosum managed with adalimumab, Nat Rev Gastroenterol Hepatol. mai, vol.5, issue.5, pp.278-81, 2008.

T. De-risi-pugliese, P. Seksik, J. Bouaziz, F. Chasset, P. Moguelet et al., Ustekinumab treatment for neutrophilic dermatoses associated with Crohn's disease: A multicenter retrospective study, J Am Acad Dermatol. mars, vol.80, issue.3, pp.781-785, 2019.

M. Vignon-pennamen and D. Wallach, Dermatoses neutrophiliques, EMC-Dermatologie, vol.11, issue.2, pp.1-9, 2016.

J. J. Bidinger, K. Sky, D. F. Battafarano, and J. S. Henning, The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome, J Am Acad Dermatol. juill, vol.65, issue.1, pp.184-91, 2011.

A. De-fonclare, K. Khosrotehrani, S. Aractingi, P. Duriez, J. Cosnes et al., Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease, Arch Dermatol. juin, vol.143, issue.6, pp.744-752, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00815839

F. Argüelles-arias, L. Castro-laria, T. Lobatón, M. Aguas-peris, M. Rojas-feria et al., Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease, Dig Dis Sci, vol.58, issue.10, pp.2949-54, 2013.

A. V. Weizman, B. Huang, S. Targan, M. Dubinsky, P. Fleshner et al., Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study, J Cutan Med Surg. avr, vol.19, issue.2, pp.125-156, 2015.

L. Afifi, I. M. Sanchez, M. M. Wallace, S. F. Braswell, A. G. Ortega-loayza et al., Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review, J Am Acad Dermatol. juin, vol.78, issue.6, pp.1195-1204, 2018.

N. S. Barbosa, S. N. Tolkachjov, R. A. El-azhary, M. Davis, M. J. Camilleri et al., Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, J Am Acad Dermatol, vol.75, issue.5, pp.931-940, 1996.

Z. M. Low and A. Mar, Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab, Australas J Dermatol, vol.59, issue.2, pp.131-135, 2018.

M. Ali and D. R. Duerksen, Ulcerative colitis and Sweet's syndrome: a case report and review of the literature, Can J Gastroenterol. mars, vol.22, issue.3, pp.296-304, 2008.

I. Catalán-serra, L. Martín-moraleda, L. Navarro-lópez, R. Gil-borrás, V. Pont-sanjuán et al., Crohn's disease and Sweet's syndrome: an uncommon association, Rev Esp Enferm Dig. mai, vol.102, issue.5, pp.331-338, 2010.

R. Lopes-caçola, M. Soares, C. Cardoso, and A. Furtado, Sweet's syndrome complicating ulcerative colitis: a rare association, BMJ Case Rep. 20 janv, 2016.

S. Lima-c-dos, R. Pinto, O. Góes-hf-de, A. N. Salles-s-de, E. Vilar et al., Sweet's syndrome associated with Crohn's disease, An Bras Dermatol. mars, vol.92, issue.2, pp.263-268, 2017.

N. Alfurayh, A. Alhumidi, and S. Alkeraye, Pyodermatitis vegetans responding to rifampicin and clindamycin, JAAD Case Rep. déc, vol.5, issue.12, pp.1078-80, 2019.

E. M. Dodd, J. R. Howard, E. D. Dulaney, S. I. Rosenthal, M. R. Wanna et al., Pyodermatitispyostomatitis vegetans associated with asymptomatic inflammatory bowel disease, Int J Dermatol, vol.56, issue.12, pp.1457-1466, 2017.

M. Nico, T. P. Hussein, V. Aoki, and S. V. Lourenço, Pyostomatitis vegetans and its relation to inflammatory bowel disease, pyoderma gangrenosum, pyodermatitis vegetans, and pemphigus, J Oral Pathol Med. sept, vol.41, issue.8, pp.584-592, 2012.

L. G. Clark, S. N. Tolkachjov, A. G. Bridges, and M. J. Camilleri, Pyostomatitis vegetans (PSV)-pyodermatitis vegetans (PDV): A clinicopathologic study of 7 cases at a tertiary referral center, J Am Acad Dermatol. 1 sept, vol.75, issue.3, pp.578-84, 2016.

H. J. Ashchyan, C. A. Nelson, S. Stephen, W. D. James, R. G. Micheletti et al., Neutrophilic dermatoses: Pyoderma gangrenosum and other bowel-and arthritis-associated neutrophilic dermatoses, J Am Acad Dermatol. déc, vol.79, issue.6, pp.1009-1031, 2018.

D. Kurtzman, T. Jones, F. Lian, and L. S. Peng, Metastatic Crohn's disease: a review and approach to therapy, J Am Acad Dermatol, vol.71, issue.4, pp.804-817, 2014.

A. Bender-heine, J. T. Grantham, S. Zaslau, and R. Jansen, Metastatic Crohn disease: a review of dermatologic manifestations and treatment, Cutis. juin, vol.99, issue.6, pp.33-40, 2017.

D. Bouchard, L. Abramowitz, G. Bouguen, C. Brochard, A. Dabadie et al., Anoperineal lesions in Crohn's disease: French recommendations for clinical practice, Tech Coloproctol. sept, vol.21, issue.9, pp.683-91, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01639851

M. Barret, V. De-parades, M. Battistella, H. Sokol, N. Lemarchand et al., Crohn's disease of the vulva, J Crohns Colitis. juill, vol.8, issue.7, pp.563-70, 2014.

C. Alexakis, K. Gordon, R. Mellor, H. Chong, P. Mortimer et al., Ano-genital Granulomatosis and Crohn's Disease: A Case Series of Males Presenting with Genital Lymphoedema, J Crohns Colitis. 1 avr, vol.11, issue.4, pp.454-463, 2017.

F. Dederichs, I. Iesalnieks, M. Sladek, C. Tzivinikos, R. Hansen et al., Genital Granulomatosis in Male and Female Patients With Crohn's Disease: Clinical Presentation and Treatment Outcomes, J Crohns Colitis. 24 janv, vol.12, issue.2, pp.197-203, 2018.

H. Campbell, M. Escudier, P. Patel, C. Nunes, T. R. Elliott et al., Distinguishing orofacial granulomatosis from crohn's disease: two separate disease entities? Inflamm Bowel Dis, vol.17, pp.2109-2124, 2011.

E. A. Hullah and M. P. Escudier, The mouth in inflammatory bowel disease and aspects of orofacial granulomatosis, Periodontol, vol.80, issue.1, pp.61-76, 2000.

D. Lauritano, E. Boccalari, D. Stasio, D. , D. Vella et al., Prevalence of Oral Lesions and Correlation with Intestinal Symptoms of Inflammatory Bowel Disease: A Systematic Review, Diagn Basel Switz, vol.15, issue.3, 2019.

K. H. Katsanos, J. Torres, G. Roda, A. Brygo, E. Delaporte et al., Review article: non-malignant oral manifestations in inflammatory bowel diseases, Aliment Pharmacol Ther. juill, vol.42, issue.1, pp.40-60, 2015.

J. Gubatan, N. D. Chou, O. H. Nielsen, and A. C. Moss, Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease, Aliment Pharmacol Ther. déc, vol.50, pp.1146-58, 2019.

F. Alinaghi, H. G. Tekin, J. Burisch, J. J. Wu, J. P. Thyssen et al., Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease -A systematic review and metaanalysis, J Crohns Colitis, 2019.

A. D. Cohen, J. Dreiher, and S. Birkenfeld, Psoriasis associated with ulcerative colitis and Crohn's disease, J Eur Acad Dermatol Venereol. mai, vol.23, issue.5, pp.561-566, 2009.

E. Delaporte, Psoriasis et maladies inflammatoires du tube digestif, Ann Dermatol Vénéréologie. avr, vol.139, pp.46-52, 2012.

Y. Fu, C. Lee, C. , and C. , Association of Psoriasis With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis, JAMA Dermatol, vol.154, issue.12, pp.1417-1440, 2018.

W. Chen, C. , and C. , Association of Hidradenitis Suppurativa With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis, JAMA Dermatol. 10 juill, 2019.

N. Kamal, B. L. Cohen, S. Buche, E. Delaporte, and J. Colombel, Features of Patients With Crohn's Disease and Hidradenitis Suppurativa, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. janv, vol.14, issue.1, pp.71-80, 2016.

I. E. Deckers, F. Benhadou, M. J. Koldijk, V. Del-marmol, B. Horváth et al., Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study, J Am Acad Dermatol. 1 janv, vol.76, issue.1, pp.49-53, 2017.

A. J. Lukach, M. I. Saul, L. K. Ferris, and J. M. Swoger, Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease, Dig Dis Sci. mars, vol.63, issue.3, pp.755-60, 2018.

S. Yamada, T. Makino, M. Jinnin, K. Sakai, S. Fukushima et al., Association of linear IgA bullous disease with ulcerative colitis: a case of successful treatment with infliximab, Dermatol Basel Switz, vol.227, issue.4, pp.295-303, 2013.

A. R. Shipman, H. Reddy, and F. Wojnarowska, Association between the subepidermal autoimmune blistering diseases linear IgA disease and the pemphigoid group and inflammatory bowel disease: two case reports and literature review, Clin Exp Dermatol, vol.37, issue.5, pp.461-469, 2012.

H. Reddy, A. R. Shipman, and F. Wojnarowska, Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature, Clin Exp Dermatol. avr, vol.38, issue.3, pp.229-259, 2013.

J. P. Touraud, Y. Dutronc, P. Tsan, E. Collet, and D. Lambert,

, Ann Dermatol Venereol. sept, vol.127, issue.8-9, pp.741-745, 2000.

S. Mittal, A. Saxena, and P. Garg, Unusual presentations of Salmonella Typhi infections in children, Trop Doct. janv, vol.39, issue.1, pp.27-35, 2009.

J. Lagier, F. Fenollar, and D. Raoult, Whipple's disease and Tropheryma whipplei infections in internal medicine. When to think about it? How to treat?

, Rev Med Interne. déc, vol.35, issue.12, pp.801-808, 2014.

J. Lagier and D. Raoult, Whipple's disease and Tropheryma whipplei infections: when to suspect them and how to diagnose and treat them, Curr Opin Infect Dis, vol.31, issue.6, pp.463-70, 2018.

P. L. Minciullo, A. Cascio, G. Barberi, and S. Gangemi, Urticaria and bacterial infections, Allergy Asthma Proc. août, vol.35, issue.4, pp.295-302, 2014.

D. Neau, E. Monlun, M. Delmas, C. Beylot, M. Longy-boursier et al.,

, Rev Med Interne, vol.16, issue.12, pp.919-941, 1995.

R. Yotsu, S. Mii, R. Hayashi, H. Harada, K. Furukawa et al., Erythema nodosum associated with Yersinia enterocolitica infection, J Dermatol. sept, vol.37, issue.9, pp.819-841, 2010.

A. Leung, K. F. Leong, and J. M. Lam, Erythema nodosum. World J Pediatr, vol.14, issue.6, pp.548-54, 2018.

X. Tarroch, P. Vives, A. Salas, and J. Moré, Subcutaneous nodules in Whipple's disease, J Cutan Pathol. août, vol.28, issue.7, pp.368-70, 2001.

V. Moos and T. Schneider, Changing paradigms in Whipple's disease and infection with Tropheryma whipplei, Eur J Clin Microbiol Infect Dis, vol.30, issue.10, pp.1151-1159, 2011.

R. F. Mégraud and F. , Helicobacter pylori infection as a cause of extra-digestive diseases: myth or reality?

, Gastroenterol Clin Biol. mars, vol.27, issue.3, pp.459-66, 2003.

M. S. Heath and A. G. Ortega-loayza, Insights Into the Pathogenesis of Sweet's Syndrome, Front Immunol, vol.10, p.414, 2019.

I. A. Hujoel, D. H. Johnson, B. Lebwohl, D. Leffler, S. Kupfer et al., Tropheryma whipplei Infection (Whipple Disease) in the USA, Dig Dis Sci. janv, vol.64, issue.1, pp.213-236, 2019.

T. Marth, V. Moos, C. Müller, F. Biagi, and T. Schneider, Tropheryma whipplei infection and Whipple's disease, Lancet Infect Dis. mars, vol.16, issue.3, pp.13-22, 2016.

G. P. Balestrieri, V. Villanacci, S. Battocchio, I. Sleiman, F. Facchetti et al., Cutaneous involvement in Whipple's disease, Br J Dermatol, vol.135, issue.4, pp.666-674, 1996.

E. Frenk, Y. Merot, I. Perez, A. M. Chamot, and J. C. Gerster,

, Ann Dermatol Venereol, vol.118, issue.2, pp.115-123, 1991.

Y. Scrivener, Dermatoses carentielles, EMC-Dermatologie, p.9, 2003.

M. Fumery, F. Brazier, E. Nguyen-khac, and J. L. Dupas, Syndrome de malabsorption, EMC-Gastro entérologie, vol.8, issue.2, pp.1-11, 2013.

M. Antonelli, M. L. Burzo, G. Pecorini, G. Massi, R. Landolfi et al., Scurvy as cause of purpura in the XXI century: a review on this « ancient » disease, Eur Rev Med Pharmacol Sci, vol.22, issue.13, pp.4355-4363, 2018.

F. Galimberti and N. A. Mesinkovska, Skin findings associated with nutritional deficiencies. CCJM, vol.83, pp.731-740, 2016.

V. Glutsch, H. Hamm, and M. Goebeler, Zinc and skin: an update, J Dtsch Dermatol Ges. juin, vol.17, issue.6, pp.589-96, 2019.

S. Ingen-housz-oro,

, Ann Dermatol Venereol. mars, vol.138, issue.3, pp.221-228, 2011.

H. Barthelemy, B. Chouvet, and F. Cambazard, Skin and mucosal manifestations in vitamin deficiency, J Am Acad Dermatol. déc, vol.15, issue.6, pp.1263-74, 1986.

G. Ponti, G. Pellacani, S. Seidenari, A. Pollio, U. Muscatello et al., Cancer-associated genodermatoses: skin neoplasms as clues to hereditary tumor syndromes, Crit Rev Oncol Hematol. mars, vol.85, issue.3, pp.239-56, 2013.

M. Kopá?ová, O. Urban, J. Cyrany, J. Laco, J. Bure? et al., Cronkhite-Canada syndrome: review of the literature, Gastroenterol Res Pract, p.856873, 2013.

K. R. Shah, C. R. Boland, M. Patel, B. Thrash, and A. Menter, Cutaneous manifestations of gastrointestinal disease: part I, J Am Acad Dermatol. févr, vol.68, issue.2, pp.189-190, 2013.

H. T. Lynch, K. Drescher, J. Knezetic, and L. S. Genetics, Hereditary Cancer Syndrome Diagnosis, Heterogeneity and Treatment: A Review, Curr Treat Options in Oncol. 1 sept, vol.15, issue.3, pp.429-471, 2014.

Z. Shen, J. D. Hoffman, F. Hao, and P. E. , More than just skin deep: faciocutaneous clues to genetic syndromes with malignancies, Oncologist, vol.17, issue.7, pp.930-936, 2012.

D. Bonnet and R. Guimbaud, Polyposes et cancers colorectaux familiaux, EMC-gastro-entérologie, vol.10, issue.4, pp.1-7, 2015.

J. Mester and C. Eng, Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndrome, J Surg Oncol. janv, vol.111, issue.1, pp.125-155, 2015.

M. P. Smerdel, A. Skytte, A. M. Jelsig, E. Ebbehøj, and K. Stochholm, Revised Danish guidelines for the cancer surveillance of patients with Cowden Syndrome, Eur J Med Genet, vol.10, issue.2020, 103873.

M. Chang, J. Wong, and Y. Chang, Screening and early detection of pancreatic cancer in high risk population, World J Gastroenterol. 7 mars, vol.20, issue.9, pp.2358-64, 2014.

C. Stefanaki and A. Stratigos, Alopecia in Cronkhite-Canada syndrome, Br J Dermatol, vol.177, issue.2, pp.348-357, 2017.

B. Cribier, Accurate diagnosis of adnexal tumours can be a matter of life or death

, Ann Dermatol Venereol. févr, vol.136, issue.2, pp.125-157, 2009.

L. E. Jenkins, S. Abner, and C. Schadt, A survey study with assessment of esophageal screening and genetic counseling in patients with Howel-Evans syndrome, Dermatol Online J. 15 juin, vol.24, issue.6, 2018.

A. M. John and R. A. Schwartz, Muir-Torre syndrome (MTS): An update and approach to diagnosis and management, J Am Acad Dermatol. mars, vol.74, issue.3, pp.558-66, 2016.

. Task-force/committee, . Members, C. I. Vidal, A. Sutton, E. A. Armbrect et al., Muir-Torre syndrome appropriate use criteria: Effect of patient age on appropriate use scores, J Cutan Pathol. juill, vol.46, issue.7, pp.484-493, 2019.

R. Macías, E. Inga, R. Rodriguez, A. Conde, E. Vergara et al., P-230Muir-Torre Syndrome diagnostic and screening. a single center experience, Ann Oncol. juin, vol.27, issue.2, p.67, 2016.

A. Ellis, J. M. Risk, T. Maruthappu, and D. P. Kelsell, Tylosis with oesophageal cancer: Diagnosis, management and molecular mechanisms, Orphanet J Rare Dis. 29 sept, vol.10, p.126, 2015.

D. C. Blaydon, S. L. Etheridge, J. M. Risk, H. Hennies, L. J. Gay et al., RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome, Am J Hum Genet, vol.90, issue.2, pp.340-346, 2012.

M. Garayar-cantero, R. Sánchez, A. , M. Fernández-lomana, and C. , Muir-Torre syndrome, Rev Clin Esp. févr, vol.219, issue.1, pp.51-53, 2019.

G. Ponti, P. De-leon, and M. , Muir-Torre syndrome, Lancet Oncol. déc, vol.6, issue.12, pp.980-987, 2005.

J. Jacques, L. Mesturoux, C. Vong, R. Legros, and V. Loustaud-ratti, Rev Med Interne. janv, vol.35, issue.1, pp.73-77, 2014.

J. S. Bittencourt-m-de, A. A. Imbiriba, O. A. Oliveira, and J. Santos, Cutaneous metastasis of colorectal cancer, An Bras Dermatol. déc, vol.93, issue.6, pp.884-890, 2018.

I. Nesseris, C. Tsamakis, S. Gregoriou, I. Ditsos, E. Christofidou et al., Cutaneous metastasis of colon adenocarcinoma: case report and review of the literature, An Bras Dermatol. déc, vol.88, issue.6, pp.56-64, 2013.

X. Tang, J. Gao, X. Yang, and X. Guo, A 10-year delayed diagnosis of blue rubber bleb nevus syndrome characterized by refractory iron-deficiency anemia: A case report and literature review, Medicine (Baltimore). juin, vol.97, issue.22, p.10873, 2018.

S. D. Kini, D. W. Yiu, R. A. Weisberg, J. F. Davila, and D. C. Chelius, Bevacizumab as Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Literature Review, Ann Otol Rhinol Laryngol. mai, vol.128, issue.5, pp.467-71, 2019.

C. Grigg, D. Anderson, and J. Earnshaw, Diagnosis and Treatment of Hereditary Hemorrhagic Telangiectasia, Ochsner J, vol.17, issue.2, pp.157-61, 2017.

F. Robert, A. Desroches-castan, S. Bailly, S. Dupuis-girod, and J. Feige, Future treatments for hereditary hemorrhagic telangiectasia, Orphanet J Rare Dis, vol.7, issue.2020, p.4

T. Kumei, Y. Toya, T. Shiohata, F. Kakuta, S. Yanai et al., Endoscopic injection sclerotherapy for duodenal vascular malformation in blue rubber bleb nevus syndrome, J Gastroenterol Hepatol, vol.34, issue.6, p.963, 2019.

P. Duffau, E. Lazarro, and J. Viallard,

, Rev Med Interne. janv, vol.35, issue.1, pp.21-28, 2014.

A. Theodoridis, A. Konstantinidou, E. Makrantonaki, and C. C. Zouboulis, Malignant and benign forms of atrophic papulosis (Köhlmeier-Degos disease): systemic involvement determines the prognosis, Br J Dermatol. janv, vol.170, issue.1, pp.110-115, 2014.

A. Theodoridis, E. Makrantonaki, and C. C. Zouboulis, Malignant atrophic papulosis (Köhlmeier-Degos disease) -A review, Orphanet J Rare Dis. 14 janv, vol.8, p.10, 2013.

P. Hu, Z. Mao, C. Liu, X. Hu, H. Kang et al., Malignant atrophic papulosis with motor aphasia and intestinal perforation: A case report and review of published works, J Dermatol. juin, vol.45, issue.6, pp.723-729, 2018.

V. Sabater-marco, V. Sanz-motilva, and R. Botella-estrada, Pseudoxanthoma Elasticum-Like Papular Eruption, Am J Dermatopathol. juin, vol.39, issue.6, pp.73-77, 2017.

Y. Guo, W. Pan, R. Cheng, H. Yu, W. Liao et al., Successful treatment of neurological malignant atrophic papulosis in child by corticosteroid combined with intravenous immunoglobulin, CNS Neurosci Ther. janv, vol.20, issue.1, pp.88-91, 2014.

G. Leftheriotis, G. Kauffenstein, J. F. Hamel, P. Abraham, L. Saux et al., The contribution of arterial calcification to peripheral arterial disease in pseudoxanthoma elasticum, PLoS ONE, vol.9, issue.5, p.96003, 2014.

C. M. Magro, X. Wang, F. Garrett-bakelman, J. Laurence, L. S. Shapiro et al., The effects of Eculizumab on the pathology of malignant atrophic papulosis, Orphanet J Rare Dis, vol.8, p.185, 2013.

A. Mareschal, J. Razanamahery, and F. Aubin, Malignant Atrophic Papulosis, JAMA Dermatol. 1 févr, vol.156, issue.2, pp.204-204, 2020.

L. D'marco, C. Soto, and F. Dapena, Pseudoxanthoma Elasticum and Cardiorenal Disease: À Case Report, Eur J Case Rep Intern Med, vol.7, issue.1, p.1260, 2020.

S. Laube, C. Moss, and . Pseudoxanthoma, Arch Dis Child. juill, vol.90, issue.7, pp.754-760, 2005.

A. S. Plomp, J. Toonstra, A. Bergen, M. R. Van-dijk, and P. De-jong, Proposal for updating the pseudoxanthoma elasticum classification system and a review of the clinical findings, Am J Med Genet A. avr, vol.152, issue.4, pp.1049-58, 2010.

D. Sur,

D. Baigrie and A. Ic, Treasure Island (FL): StatPearls Publishing, StatPearls, 2020.

Z. Kaddioui, F. Hali, E. Fetoiki, F. Z. Chiheb, and S. , Blue rubber bleb nevus syndrome : un nouveau cas traité par sirolimus, Ann Dermatol Vénéréol. 1 mai, vol.145, issue.4, pp.21-23, 2018.

B. Zhang, L. Li, N. Zhang, M. Zhao, Y. Liu et al., Efficacy and safety of sirolimus in the treatment of blue rubber bleb naevus syndrome in paediatric patients, Clin Exp Dermatol. Janv, vol.45, issue.1, pp.79-85, 2020.

K. Scott, A. Morris, and B. Marais, Medical student use of digital learning resources, Clin Teach, vol.15, issue.1, pp.29-33, 2018.

L. Wynter, A. Burgess, E. Kalman, J. E. Heron, and J. Bleasel, Medical students: what educational resources are they using, BMC Med Educ, vol.19, issue.1, p.36, 2019.

M. Abdolrasulnia, B. C. Collins, L. Casebeer, T. Wall, C. Spettell et al., Using email reminders to engage physicians in an Internet-based CME intervention, BMC Med Educ, vol.4, issue.1, p.17, 2004.

A. Vaona, R. Banzi, K. H. Kwag, G. Rigon, D. Cereda et al., E-learning for Health Professionals

, The Cochrane database of systematic reviews, Cochrane Database Syst Rev, vol.1, 2018.

B. Gerbert, A. Bronstone, T. Maurer, T. Berger, S. J. Mcphee et al., The effectiveness of an Internet-based tutorial in improving primary care physicians' skin cancer triage skills, J Cancer Educ, vol.17, issue.1, pp.7-11, 2002.

C. M. Weston, C. N. Sciamanna, and D. B. Nash, Evaluating Online Continuing Medical Education Seminars: Evidence for Improving Clinical Practices, Am J Med Qual, vol.23, issue.6, pp.475-83, 2008.

S. Devey, Élaboration d'un e-learning sur les manifestations dermatologiques associées à la polyarthrite rhumatoïde et aux spondylarthrites, Sciences du Vivant

B. Galand, Le numérique va-t-il révolutionner l'éducation?

L. Cahiers-de-recherche-du-girsef, , vol.2020, p.120

D. Frau-meigs and . Pédagogie-À-distance, The Conversation
URL : https://hal.archives-ouvertes.fr/hal-01875186

T. Jowsey, G. Foster, P. Cooper-ioelu, and S. Jacobs, Blended learning via distance in pre-registration nursing education: A scoping review, Nurse Educ Pract, vol.44, p.102775, 2020.

Q. Liu, W. Peng, F. Zhang, R. Hu, Y. Li et al., The Effectiveness of Blended Learning in Health Professions: Systematic Review and Meta-Analysis, J Med Internet Res, vol.18, issue.1, p.2, 2016.

V. Munro, A. Morello, C. Oster, C. Redmond, A. Vnuk et al., E-learning for self management support Introducing blended learning for graduate students: -A cohort study, BMC Med Educ, vol.18, issue.1, p.219, 2018.

S. M. Salter, A. Karia, F. M. Sanfilippo, and R. M. Clifford, Effectiveness of E-learning in Pharmacy Education, Am J Pharm Educ. 1 mai, vol.78, issue.4, p.83, 2014.

D. S. Bell, C. E. Harless, J. K. Higa, E. L. Bjork, R. A. Bjork et al., Knowledge Retention after an Online Tutorial: A Randomized Educational Experiment among Resident Physicians, J Gen Intern Med. 1 août, vol.23, issue.8, pp.1164-71, 2008.

, Direction Générale de l'Enseignement Supérieur et de l'Insertion Professionnelle. Plan de continuité pédagogique, DGESIP

, Ministère de l'enseignement supérieur, de la recherche et de l'innovation. mars 2020, ANNEXE I : Supports de e-learning sur les manifestations dermatologiques des pathologies digestives

, Réponses : a, b, c Réponses : a, d Réponses : a, b, c, d, e Réponses : b, e Réponses : a, b, c, d, e 2.2.Test sur les infections bactériennes du tube digestif Réponses : a, e Réponses : a, b, c, d, e Réponses : e 2.3.Test sur le syndrome de malabsorption Réponses : a, b, c, d, e Réponses : a, b, c, d, e Réponses : a, d, e Réponses : a, b, d, e 2.4.Test sur les manifestations cutanées des tumeurs malignes digestives Réponses : a, b

A. Iii, Cas cliniques

S. Protée and . Le-syndrome-de-bannayan-riley-ruvalcaba, Réponse : Par ordre décroissant chez l'homme : thyroïde, rein, colon Par ordre décroissant chez la femme : sein, thyroïde, endomètre

. Dans-la-mesure-où-le-traitement-est-efficace-sur-le-plan, . Digestif, and . Qu, il est habituel que les manifestations cutanées aient un temps de réponse plus long, il faut maintenir l'anti-TNF. On peut ajouter des dermocorticoïdes en attendant l'efficacité du traitement. Réponse : Switch de l'immunothérapie, dans l'hypothèse d'une réaction paradoxale

M. Benzaquen, J. Monnier, Y. Beaussault, F. Rouby, and P. Berbis, Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab, Australas J Dermatol, vol.58, pp.270-271, 2017.

, Réponse : Il s'agit d'un zona généralisé

, Il faut hospitaliser le patient en urgence, arrêter la biothérapie et instaurer un traitement par aciclovir IV 10mg/kg toutes les 8 heures pour une durée de 10 jours

. Il, Isolement respiratoire et contact. -réaliser un TDM-thoracique low-dose pour recherche une atteinte pulmonaire -réaliser un bilan biologique avec : NFS, bilan hépatique et rénale -en cas de signe de surinfection : antibiothérapie associée locale et systémique, p.141

A. Iv, Questionnaire de satisfaction RESUME Introduction : Les formations en ligne sont de plus en plus développées

L. , élaborer un e-learning sur les manifestations dermatologiques des pathologies digestives destiné aux internes inscrits en D.E.S. de Dermatologie-Vénéréologie à l

. Matériel,

, Les cours étaient sous forme de diapositives, il y avait également des QCM et trois cas cliniques pour que les internes puissent s'évaluer. Ils devaient ensuite répondre à un questionnaire de satisfaction. Résultats : 16 internes, soit 100% de l'effectif

, La durée pour la réaliser était d'au moins 3 heures pour 63% des internes

, L'ensemble des internes trouvait la formation utile, pensait reconsulter ce cours durant son cursus et trouvait avoir progressé sur les manifestations dermatologiques des pathologies digestives

, Une majorité (56%) d'internes aurait préféré un cours magistral

, Nous avons fait une correction en visioconférence car la situation sanitaire ne nous permettait pas de nous réunir. Conclusion : Le e-learning est un mode d'enseignement bien développé et qui a montré son efficacité, 81% des internes ont trouvé les cas cliniques difficilement abordables et trouvé utile d'en faire une correction en présentiel

, Il semblerait qu'une association entre cours en présentiel et cours en ligne c'est-à-dire de type blended learning soit la meilleure combinaison pour pallier le sentiment de solitude

, Mots clés : e-learning, dermatologie, gastroentérologie, maladies inflammatoires chroniques de l'intestin